High transcriptional complexity of the retinitis pigmentosa CERKL gene in human and mouse

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 8, 2011, Pages 5202-5214

  Garanto, Alejandro ^a,b   Riera, Marina ^a,b   Pomares, Esther ^a,b   Permanyer, Jon ^a   de Castro Miró, Marta ^a   Sava, Florentina ^a   Abril, Josep F ^a   Marfany, Gemma ^a,b   Gonzàlez Duarte, Roser ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; CERKL GENE; COMPUTER MODEL; GENE; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RETINA GANGLION CELL; RETINITIS PIGMENTOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECIES DIFFERENCE; TRANSCRIPTION INITIATION SITE; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL STRAIN HEK293; GENETICS; GENOMICS; GENOTYPE; METHODOLOGY; PHENOTYPE; PHYSIOLOGY; RETINA; RETINA CONE; RETINA ROD;

CERAMIDE KINASE; CERKL PROTEIN, MOUSE; PHOSPHOTRANSFERASE;

ALTERNATIVE SPLICING; ANIMALS; GENOMICS; GENOTYPE; HEK293 CELLS; HUMANS; MICE; MICE, INBRED C57BL; PHENOTYPE; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROMOTER REGIONS, GENETIC; RETINA; RETINAL CONE PHOTORECEPTOR CELLS; RETINAL GANGLION CELLS; RETINAL ROD PHOTORECEPTOR CELLS; RETINITIS PIGMENTOSA; SPECIES SPECIFICITY; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION, GENETIC;

EID: 80052812495     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-7101     Document Type: Article

References (56)

1. Sultan M, Schulz MH, Richard H, et al. A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome. Science. 2008;321:956-960.
2. Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet. 2008;40:1413-1415.
3. Nilsen TW, Graveley BR. Expansion of the eukaryotic proteome by alternative splicing. Nature. 463:457-463.
4. Licatalosi DD, Darnell RB. RNA processing and its regulation: global insights into biological networks. Nat Rev Genet. 2010;11: 75-87.
5. McGlincy NJ, Smith CW. Alternative splicing resulting in nonsensemediated mRNA decay: what is the meaning of nonsense? Trends Biochem Sci. 2008;33:385-393.
6. Tazi J, Bakkour N, Stamm S. Alternative splicing and disease. Biochim Biophys Acta. 2009;1792:14-26.
7. Raponi M, Baralle D. Alternative splicing: good and bad effects of translationally silent substitutions. FEBS J. 2010;277:836-840.
8. Ward AJ, Cooper TA. The pathobiology of splicing. J Pathol. 2010;220:152-163.
9. Xu X, Liu Y, Weiss S, Arnold E, Sarafianos SG, Ding J. Molecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design. Nucleic Acids Res. 2003;31:7117-7130.
10. McCullough RM, Cantor CR, Ding C. High-throughput alternative splicing quantification by primer extension and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Nucleic Acids Res. 2005;33:e99.
11. Licatalosi DD, Darnell RB. Splicing regulation in neurologic disease. Neuron. 2006;52:93-101.
12. Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006;368:1795-1809.
13. Beit-Ya'acov A, Mizrahi-Meissonnier L, Obolensky A, et al. Homozygosity for a novel ABCA4 founder splicing mutation is associated with progressive and severe Stargardt-like disease. Invest Ophthalmol Vis Sci. 2007;48:4308-4314.
14. Schmid F, Glaus E, Cremers FP, Kloeckener-Gruissem B, Berger W, Neidhardt J. Mutation-and tissue-specific alterations of RPGR transcripts. Invest Ophthalmol Vis Sci. 2010;51:1628-1635.
15. Riazuddin SA, Iqbal M, Wang Y, et al. A splice-site mutation in a retina-specific exon of BBS8 causes nonsyndromic retinitis pigmentosa. Am J Hum Genet. 2010;86:805-812.
16. Wang Y, Juranek S, Li H, Sheng G, Tuschl T, Patel DJ. Structure of an argonaute silencing complex with a seed-containing guide DNA and target RNA duplex. Nature. 2008;456:921-926.
17. Tuson M, Marfany G, Gonzalez-Duarte R. Mutation of CERKL, a novel human ceramide kinase gene, causes autosomal recessive retinitis pigmentosa (RP26). Am J Hum Genet. 2004;74:128-138.
18. Bornancin F, Mechtcheriakova D, Stora S, et al. Characterization of a ceramide kinase-like protein. Biochim Biophys Acta. 2005;1687: 31-43.
19. Tuson M, Garanto A, Gonzalez-Duarte R, Marfany G. Overexpression of CERKL, a gene responsible for retinitis pigmentosa in humans, protects cells from apoptosis induced by oxidative stress. Mol Vis. 2009;15:168-180.
20. Mendez A, Lem J, Simon M, Chen J. Light-dependent translocation of arrestin in the absence of rhodopsin phosphorylation and transducin signaling. J Neurosci. 2003;23:3124-3129.
21. Rhead B, Karolchik D, Kuhn RM, et al. The UCSC Genome Browser database: update. Nucleic Acids Res. 2010;38:D613-D619.
22. Frazer KA, Pachter L, Poliakov A, Rubin EM, Dubchak I. VISTA: computational tools for comparative genomics. Nucleic Acids Res. 2004;32:W273-W279.
23. Tatusova TA, Madden TL. BLAST 2 Sequences, a new tool for comparing protein and nucleotide sequences. FEMS Microbiol Lett. 1999;174:247-250.
24. Pruitt KD, Tatusova T, Klimke W, Maglott DR. NCBI Reference Sequences: current status, policy and new initiatives. Nucleic Acids Res. 2009;37:D32-D36.
25. Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Sayers EW. GenBank Nucleic Acids Res. 2009;37:D26-D31.
26. Wakaguri H, Yamashita R, Suzuki Y, Sugano S, Nakai K. DBTSS: database of transcription start sites, progress report 2008. Nucleic Acids Res. 2008;36:D97-D101.
27. Harrow J, Denoeud F, Frankish A, et al. GENCODE: producing a reference annotation for ENCODE. Genome Biol. 2006;7(suppl 1):S41-S49.
28. Slater GS, Birney E. Automated generation of heuristics for biological sequence comparison. BMC Bioinformatics. 2005;6:31.
29. Davuluri RV, Grosse I, Zhang MQ. Computational identification of promoters and first exons in the human genome. Nat Genet. 2001;29:412-417.
30. Bailey TL, Boden M, Buske FA, et al. MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res. 2009;37:W202-W208.
31. Matys V, Fricke E, Geffers R, et al. TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res. 2003;31: 374-378.
32. Messeguer X, Escudero R, Farre D, Nunez O, Martinez J, Alba MM. PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics. 2002;18:333-334.
33. Portales-Casamar E, Thongjuea S, Kwon AT, et al. JASPAR: the greatly expanded open-access database of transcription factor binding profiles. Nucleic Acids Res. 2010;38:D105-D110.
34. Kozak M. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 1987;15:8125-8148.
35. Celniker SE, Dillon LA, Gerstein MB, et al. Unlocking the secrets of the genome. Nature. 2009;459:927-930.
36. Ruthenburg AJ, Allis CD, Wysocka J. Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol Cell. 2007;25:15-30.
37. Auslender N, Sharon D, Abbasi AH, Garzozi HJ, Banin E, Ben-Yosef T. A common founder mutation of CERKL underlies autosomal recessive retinal degeneration with early macular involvement among Yemenite Jews. Invest Ophthalmol Vis Sci. 2007;48:5431-5438.
38. Inagaki Y, Mitsutake S, Igarashi Y. Identification of a nuclear localization signal in the retinitis pigmentosa-mutated RP26 protein, ceramide kinase-like protein. Biochem Biophys Res Commun. 2006;343:982-987.
39. Rovina P, Schanzer A, Graf C, Mechtcheriakova D, Jaritz M, Bornancin F. Subcellular localization of ceramide kinase and ceramide kinase-like protein requires interplay of their pleckstrin homology domain-containing N-terminal regions together with C-terminal domains. Biochim Biophys Acta. 2009;1791:1023-1030.
40. Barash Y, Calarco JA, Gao W, et al. Deciphering the splicing code. Nature. 2010;465:53-59.
41. Tejedor JR, Valcarcel J. Gene regulation: Breaking the second genetic code. Nature. 2010;465:45-46.
42. Lu X, Ferreira PA. Identification of novel murine-and humanspecific RPGRIP1 splice variants with distinct expression profiles and subcellular localization. Invest Ophthalmol Vis Sci. 2005;46: 1882-1890.
43. Neidhardt J, Glaus E, Barthelmes D, Zeitz C, Fleischhauer J, Berger W. Identification and characterization of a novel RPGR isoform in human retina. Hum Mutat. 2007;28:797-807.
44. Wang XP, Cooper NG. Characterization of the transcripts and protein isoforms for cytoplasmic polyadenylation element binding protein-3 (CPEB3) in the mouse retina. BMC Mol Biol. 2009;10:109.
45. Tanackovic G, Ransijn A, Thibault P, et al. PRPF mutations are associated with generalized defects in spliceosome formation and pre-mRNA splicing in patients with retinitis pigmentosa. Hum Mol Genet. 2011;20:2116-2130.
46. Spellicy CJ, Daiger SP, Sullivan LS, et al. Characterization of retinal inosine monophosphate dehydrogenase 1 in several mammalian species. Mol Vis. 2007;13:1866-1872.
47. Akepati VR, Muller EC, Otto A, Strauss HM, Portwich M, Alexander C. Characterization of OPA1 isoforms isolated from mouse tissues. J Neurochem. 2008;106:372-383.
48. Tanackovic G, Rivolta C. PRPF31 alternative splicing and expression in human retina. Ophthalmic Genet. 2009;30:76-83.
49. Kirschner R, Rosenberg T, Schultz-Heienbrok R, et al. RPGR transcription studies in mouse and human tissues reveal a retinaspecific isoform that is disrupted in a patient with X-linked retinitis pigmentosa. Hum Mol Genet. 1999;8:1571-1578.
50. de Lima Morais DA, Harrison PM. Large-scale evidence for conservation of NMD candidature across mammals. PLoS One. 5:e11695.
51. Pomares E, Marfany G, Brión MJ, et al. Novel high-throughput SNP genotyping cosegregation analysis for genetic diagnosis of autosomal recessive retinitis pigmentosa and Leber congenital amaurosis. Hum Mutat. 2007;28:511-516.
52. Avila-Fernandez A, Riveiro-Alvarez R, Vallespin E, et al. CERKL mutations and associated phenotypes in seven Spanish families with autosomal recessive retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2008;49:2709-2713.
53. Aleman TS, Soumittra N, Cideciyan AV, et al. CERKL mutations cause an autosomal recessive cone-rod dystrophy with inner retinopathy. Invest Ophthalmol Vis Sci. 2009;50:5944-5954.
54. Littink KW, Koenekoop RK, van den Born LI, et al. Homozygosity mapping in patients with cone-rod dystrophy: novel mutations and clinical characterizations. Invest Ophthalmol Vis Sci. 2010;51: 5943-5951.
55. Ali M, Ramprasad VL, Soumittra N, et al. A missense mutation in the nuclear localization signal sequence of CERKL (p. R106S) causes autosomal recessive retinal degeneration. Mol Vis. 2008;14: 1960-1964.
56. Tang Z, Wang Z, Wang Z, et al. Novel compound heterozygous mutations in CERKL cause autosomal recessive retinitis pigmentosa in a nonconsanguineous Chinese family. Arch Ophtalmol. 2009;127:1077-1078.